The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPageGroup Regulatory News (PAGE)

Share Price Information for PageGroup (PAGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 447.80
Bid: 446.60
Ask: 448.80
Change: 2.40 (0.54%)
Spread: 2.20 (0.493%)
Open: 450.00
High: 451.80
Low: 441.40
Prev. Close: 445.40
PAGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of new Chair

21 Dec 2021 11:02

RNS Number : 3543W
PageGroup plc
21 December 2021
 

21 December 2021

 

PageGroup plc

Appointment of new Chair

 

PageGroup plc, the specialist recruitment consultancy (the "Company") is pleased to announce that Angela Seymour-Jackson has been appointed as Chair-designate with effect from today. Angela Seymour-Jackson will succeed David Lowden as Chair when he retires from the Board on 30 April 2022. David Lowden has served on the Board since August 2012. Angela Seymour-Jackson's appointment follows a thorough and comprehensive process undertaken by the Nomination Committee, led by Patrick De Smedt, Senior Independent Director.

 

Angela Seymour-Jackson joined the Company as a Non-Executive Director in 2017 having previously been Chief Executive of RAC Limited. She has also held senior Executive roles with Aegon UK and Aviva UK Limited, and was Senior Advisor to Lloyds Banking Group (Insurance). Angela Seymour-Jackson is an experienced Non-Executive Director and Committee Chair currently serving on the Boards of Trustpilot, Future and Janus Henderson, having previously been a member of the Boards of GoCo, Rentokil Initial and esure.

 

On appointment as Chair, and in line with the UK Corporate Governance Code, Angela Seymour-Jackson will step down as Chair of the Remuneration Committee and will cease to be a member of this Committee. With effect from 1 May 2022, Angela Seymour-Jackson will also cease to be a member of the Company's Audit Committee and will become Chair of the Company's Nomination Committee. The Nomination Committee will commence a recruitment process to appoint a new Non-Executive Director and Chair of the Remuneration Committee in due course.

 

Angela Seymour-Jackson, Chair-designate commented:

 

"I am delighted to have been appointed as Chair of PageGroup. I look forward to leading the Board as we continue to drive Page forward in providing market leading recruitment services to our customers globally. I would also like to thank David for his wisdom and commitment during his time on the Board."

 

Steve Ingham, Chief Executive Officer commented:

 

"Angela has proven herself to be a valued member of the Board as a Non-Executive Director and Chair of the Remuneration Committee and we are really pleased that she has been appointed as the new Chair of Pagegroup."

 

 

ENDS

 

 

 

Kaye Maguire

 

General Counsel & Company Secretary

 

Tel: +44 203 077 8069

 

 

Notes:

 

1. The Board currently considers Angela Seymour-Jackson to be an independent non-executive director in accordance with the UK Corporate Governance Code and have determined that she will be independent upon appointment as Chair.

 

2. Angela Seymour-Jackson will receive an annual fee of £225k per annum in respect of the Chair duties from 1 May 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZMZZGMKGMZM
Date   Source Headline
15th Apr 20247:00 amRNSTrading Update
12th Apr 20243:48 pmRNSAnnual Report & Accounts & Notice of AGM
11th Apr 202411:18 amRNSHolding(s) in Company
11th Apr 20249:30 amRNSNotice of First Quarter 2024 Trading Update
18th Mar 20242:20 pmRNSDirector/PDMR Shareholding
18th Mar 20242:15 pmRNSDirector/PDMR Shareholding
13th Mar 202412:17 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFull Year Results for the Year Ended 31 Dec 2023
4th Mar 20243:18 pmRNSNotice of 2023 Full Year Results
15th Jan 20247:00 amRNSTrading Update
11th Jan 20249:43 amRNSNotice of Q4 and Full Year 2023 Trading Update
27th Nov 20231:59 pmRNSHolding(s) in Company
11th Oct 20237:00 amRNSQ3 Trading Statement
10th Oct 20239:53 amRNSNotice of Third Quarter 2023 Trading Update
27th Sep 20233:00 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSCapital Markets Event
7th Aug 20232:52 pmRNSHolding(s) in Company
7th Aug 20237:00 amRNSHalf Year Results for the Period Ended 30 June 23
2nd Aug 20234:27 pmRNSNotice of 2023 Half Year Results
20th Jul 20232:18 pmRNSHolding(s) in Company
18th Jul 20233:23 pmRNSHolding(s) in Company
18th Jul 20231:57 pmRNSHolding(s) in Company
12th Jul 202311:27 amRNSHolding(s) in Company
12th Jul 20237:00 amRNSTrading Update
10th Jul 202310:18 amRNSNotice of Second Quarter 2023 Trading Update
20th Jun 20233:36 pmRNSHolding(s) in Company
14th Jun 202311:51 amRNSHolding(s) in Company
6th Jun 20237:00 amRNSInteractive Investor Event
1st Jun 20231:47 pmRNSResult of AGM
19th Apr 20234:25 pmRNSHolding(s) in Company
17th Apr 20237:00 amRNSQ1 Trading Statement
13th Apr 20232:19 pmRNSNotice of First Quarter 2023 Trading Update
13th Apr 202310:35 amRNSAnnual Report & Accounts & Notice of AGM
3rd Apr 20235:42 pmRNSHolding(s) in Company
24th Mar 202310:41 amRNSDirector/PDMR Shareholding
23rd Mar 202312:45 pmRNSHolding(s) in Company
16th Mar 202312:34 pmRNSDirector/PDMR Shareholding
16th Mar 202312:28 pmRNSDirector/PDMR Shareholding
14th Mar 202312:37 pmRNSDirector/PDMR Shareholding
14th Mar 202312:35 pmRNSDirector/PDMR Shareholding
9th Mar 20237:00 amRNSFull Year Results for the Year Ended 31 Dec 2022
7th Mar 20235:37 pmRNSBoard Changes
2nd Mar 20231:55 pmRNSNotice of 2022 Full Year Results
11th Jan 20237:00 amRNSFOURTH QUARTER AND FULL YEAR 2022 TRADING UPDATE
9th Jan 20232:23 pmRNSNotice of Q4 and Full Year 2022 Trading Update
23rd Dec 20227:00 amRNSBoard Changes
18th Oct 20227:00 amRNSAppointment of Chief Executive Officer Designate
12th Oct 20227:00 amRNSThird Quarter 2022 Trading Update
11th Oct 20229:28 amRNSNotice of Third Quarter 2022 Trading Update
8th Aug 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.